文献速递临床试验与 GCP流行病学与生物统计

全静脉麻醉与挥发性吸入麻醉在大型非心脏手术中的随机临床试验

Total Intravenous vs Volatile Inhalational Anesthesia for Major Noncardiac Surgery: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2026-01-01

该实用型多中心开放标签随机试验纳入2508例50岁以上择期大型非心脏手术患者,比较丙泊酚全静脉麻醉(TIVA)与挥发性吸入麻醉。

要点

  • TIVA与吸入麻醉在30天存活且在家天数上无差异。
  • TIVA组口渴、声嘶、恶心呕吐发生率较低。
  • 两组谵妄和主要并发症发生率相似。

核心结论

  • 在50岁以上接受大型非心脏手术的成人中,与吸入麻醉相比,TIVA未改善30天存活且在家天数。

研究设计与样本

  • 纳入50岁及以上择期大型非心脏手术患者,按1:1随机接受TIVA(丙泊酚输注,n=1254)或挥发性吸入麻醉(n=1254),其他围手术期管理由临床医生决定。

主要发现

  • 90天存活且在家天数、30天/90天/6个月死亡率、第3天Quality of Recovery-15评分两组均无差异。
  • TIVA组口渴、声嘶、恶心呕吐发生率较低;两组谵妄水平相似,第3天87.6%无谵妄。
  • 总体主要并发症发生率为12.4%,组间无显著差异;TIVA组报告2例确定或可能的术中知晓。

临床怎么用

  • 对于50岁以上大型非心脏手术患者,选择TIVA或吸入麻醉时,30天存活且在家天数不应作为决策依据。
  • TIVA可能减少口渴、声嘶、恶心呕吐,但需权衡术中知晓风险。

局限性

  • 开放标签设计可能影响患者报告结局;其他围手术期管理由临床医生决定,存在异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Older adults undergoing major noncardiac surgery experience substantial postoperative morbidity and health care use. The comparative effectiveness of total intravenous anesthesia (TIVA) vs volatile-based inhalational anesthesia on recovery and safety remains uncertain. OBJECTIVES: To determine whether TIVA improves days alive and at home at 30 days compared with inhalational anesthesia and to evaluate differences in patient-centered outcomes and recovery. DESIGN, SETTING, AND PARTICIPANTS: Pragmatic, multicenter, open-label randomized clinical trial conducted in 49 UK National Health Service hospitals from January 2022 to April 2024 (final follow-up, October 2024) among patients aged 50 years or older scheduled for elective major noncardiac surgery. INTERVENTIONS: Participants were randomized 1:1 to receive maintenance of general anesthesia with either TIVA (propofol infusion) (n = 1254) or volatile-based inhalational agents (n = 1254). All other perioperative care was at clinician discretion. MAIN OUTCOMES AND MEASURES: The primary outcome was days alive and at home at 30 days. Secondary outcomes included days alive and at home at 90 days; mortality at 30 days, 90 days, and 6 months; Quality of Recovery-15 score at day 3; patient satisfaction (Bauer Patient Satisfaction Questionnaire) at day 1; delirium (4 As Test [4AT]) at day 3; unintentional awareness under anesthesia; and major postoperative complications within 30 days. RESULTS: Among the 2508 randomized participants, the mean age was 67 (SD, 8.9) years, and 55% were male. Characteristics were balanced across randomized groups. Days alive and at home at 30 days were similar between groups (mean, 22.5 [SD, 6.8] days vs 22.4 [SD, 6.6] days for TIVA vs inhalational anesthesia, respectively; incidence rate ratio, 1.00; 95% CI, 0.99-1.02; adjusted P = .68). There were no differences in days alive and at home at 90 days; mortality at 30 days, 90 days, or 6 months; or Quality of Recovery-15 score at day 3. Lower rates of thirst, hoarseness, and nausea and vomiting were reported in the TIVA group. Levels of delirium were similar between groups, with the majority (87.6%) having no delirium at day 3. Major complications occurred in 12.4% of patients overall, with no significant between-group differences. Two cases of certain or probable unintentional awareness under anesthesia were reported, both in the TIVA group. CONCLUSIONS AND RELEVANCE: Among older adults undergoing major noncardiac surgery, TIVA did not improve days alive and at home at 30 days compared with inhalational anesthesia. TRIAL REGISTRATION: ISRCTN.org Identifier: ISRCTN62903453.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Jhanji S, Booth K, Hiller L, et al. Total Intravenous vs Volatile Inhalational Anesthesia for Major Noncardiac Surgery: A Randomized Clinical Trial. JAMA. 2026. PMID: 42584898. doi:10.1001/jama.2026.11065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。